Adenovirus facilitation of molecular conjugate-mediated gene transfer.

Adenovirus facilitation of molecular conjugate-mediated gene transfer. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Adenovirus facilitation of molecular conjugate-mediated gene transfer. Abstract Text:

Adenovirus facilitation of molecular conjugate-mediated gene transfer. Publishing Authors By Initials

For similar investigative techniques: genetic techniques: gene transfer techniques: transfection research abstracts see: investigative techniques: genetic techniques: gene transfer techniques: transfection research

PUBMED ID PMID:

MEDLINE DATE:

Adenovirus facilitation of molecular conjugate-mediated gene transfer. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Progress in medical virology. Fortschritte der med

VOLUME: 40

Page Numbers: 1-18

Journal Abbreviation: Prog. Med. Virol.

ISSN: 0079-645X

DAY: 26

MONTH: 02

YEAR: 1993

Adenovirus facilitation of molecular conjugate-mediated gene transfer. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 376451

Adenovirus facilitation of molecular conjugate-mediated gene transfer. Keywords Mesh Terms:

KEYWORDS: Transfection

MESH TERMS: methods

Chemical & Substance for Abstract: Adenovirus facilitation of molecular conjugate-mediated gene transfer. Information

Substance Name: DNA, Viral

Registry Number: 0

Grant and Affiliation Information for Adenovirus facilitation of molecular conjugate-mediated gene transfer.

AFFILIATION: Department of Medicine, University of North Carolina, Chapel Hill.

Country: SWITZERLAND

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Prog Med Virol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Adenovirus facilitation of molecular conjugate-mediated gene transfer Related Publications

• A fiber-modified mesothelin promoter-based conditionally replicating adenovirus for treatment of ovarian cancer.
• A mosaic fiber adenovirus serotype 5 vector containing reovirus sigma 1 and adenovirus serotype 3 knob fibers increases transduction in an ovarian cancer ex vivo system via a coxsackie and adenovirus receptor-independent pathway.
• A three-dimensional assay for measurement of viral-induced oncolysis.
• Adenovirus facilitation of molecular conjugate-mediated gene transfer.
• Characterization of infectivity of knob-modified adenoviral vectors in glioma.
• Development of an optimized conditionally replicative adenoviral agent for ovarian cancer.
• Drugs Designed To Inhibit Human p38 Mitogen-Activated Protein Kinase Activation Treat Toxoplasma gondii and Encephalitozoon cuniculi Infection.
• Fiber-modified Adenoviruses for Targeted Gene Therapy.
• Fracture complicating the bone marrow edema syndrome.
• Gene therapy for renal cancer.
• Gene therapy: human germline genetic modifications--assessing the scientific, socioethical, and religious issues.
• Improved anti-tumor therapy based upon infectivity-enhanced adenoviral delivery of RNA interference in ovarian carcinoma cell lines.
• Introduction to special issue on cellular vehicles.
• Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma.
• New generation adenoviral vectors improve gene transfer by coxsackie and adenoviral receptor-independent cell entry.
• Optimization of capsid-incorporated antigens for a novel adenovirus vaccine approach.
• Regulatory T cells and treatment of cancer.
• Regulatory T cells: a new frontier in cancer immunotherapy.
• Targeting EGFR with metabolically biotinylated fiber-mosaic adenovirus.
• Targeting lung cancer using an infectivity enhanced CXCR4-CRAd.
• Targeting mesothelioma using an infectivity enhanced survivin-conditionally replicative adenoviruses.
• Targeting of a conditionally replicative adenovirus agent to human squamous cell carcinomas of the head and neck.
• Thermostability/infectivity defect caused by deletion of the core protein V gene in human adenovirus type 5 is rescued by thermo-selectable mutations in the core protein X precursor.
• Toxoplasma gondii expresses two mitogen-activated protein kinase genes that represent distinct protozoan subfamilies.
• Tregs and rethinking cancer immunotherapy.
• [Not Available.]
• [Principal causes of death; need for a uniform method of determination for international purposes.]
• [Report of the activities of the Latin American Center of Classification of Diseases in relation to the revision of 1995.]